IRONWOOD PHARMACEUTICALS, INC. Restructuring Reserve
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Restructuring Reserve of $773.00 thousand as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2026-02-26
- 2025-12-31: Restructuring Reserve $773.00K.
- 2024-12-31: Restructuring Reserve $615.00K.
- 2023-12-31: Restructuring Reserve $8.37M.
- 2023-09-30: Restructuring Reserve $10.71M.
| Period end | Restructuring Reserve |
|---|---|
| 2025-12-31 | $773.00K 10-K · filed 2026-02-26 |
| 2024-12-31 | $615.00K 10-K · filed 2026-02-26 |
| 2023-12-31 | $8.37M 10-K · filed 2026-02-26 |
| 2023-09-30 | $10.71M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $11.35M 10-Q · filed 2023-08-09 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-16 |
| 2021-12-31 | $462.00K 10-K · filed 2023-02-16 |
| 2021-09-30 | $948.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $2.28M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $5.81M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $10.91M 10-K · filed 2023-02-16 |
| 2018-03-31 | $1.16M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $0.00 10-Q · filed 2018-05-04 |
| 2014-09-30 | $101.00K 10-Q · filed 2014-11-05 |
| 2014-06-30 | $373.00K 10-Q · filed 2014-08-05 |
| 2014-03-31 | $1.50M 10-Q · filed 2014-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |